|
Avaliação DCF profunda Medical Corp. (Prof) |
Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
Design Profissional: Modelos Confiáveis E Padrão Da Indústria
Pré-Construídos Para Uso Rápido E Eficiente
Compatível com MAC/PC, totalmente desbloqueado
Não É Necessária Experiência; Fácil De Seguir
Profound Medical Corp. (PROF) Bundle
Procurando avaliar o valor intrínseco da profunda Medical Corp.? Nossa calculadora DCF ProF integra dados do mundo real com recursos abrangentes de personalização, permitindo refinar suas projeções e aprimorar suas estratégias de investimento.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.3 | 5.0 | 4.9 | 5.2 | 7.8 | 8.7 | 9.7 | 10.9 | 12.2 | 13.6 |
| Revenue Growth, % | 0 | -5.9 | -2.79 | 7.75 | 48.35 | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 |
| EBITDA | -14.2 | -20.8 | -18.6 | -19.5 | -24.0 | -8.7 | -9.7 | -10.9 | -12.2 | -13.6 |
| EBITDA, % | -266.92 | -416.82 | -382.43 | -372.01 | -309.57 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.5 | 1.7 | 1.5 | .8 | .0 | 1.9 | 2.1 | 2.4 | 2.7 | 3.0 |
| Depreciation, % | 28.24 | 34.28 | 31.26 | 15.92 | 0 | 21.94 | 21.94 | 21.94 | 21.94 | 21.94 |
| EBIT | -15.7 | -22.5 | -20.1 | -20.3 | -24.0 | -8.7 | -9.7 | -10.9 | -12.2 | -13.6 |
| EBIT, % | -295.17 | -451.1 | -413.68 | -387.93 | -309.57 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 61.0 | 48.8 | 33.8 | 19.1 | 39.9 | 8.7 | 9.7 | 10.9 | 12.2 | 13.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 5.4 | 1.0 | 4.6 | 5.3 | 5.1 | 6.6 | 7.4 | 8.3 | 9.3 | 10.4 |
| Account Receivables, % | 101.74 | 20.54 | 94.96 | 101.24 | 65.96 | 76.29 | 76.29 | 76.29 | 76.29 | 76.29 |
| Inventories | 3.9 | 5.4 | 5.8 | 5.1 | 4.2 | 7.4 | 8.2 | 9.2 | 10.3 | 11.5 |
| Inventories, % | 72.99 | 107.86 | 118.86 | 97.08 | 54.32 | 84.88 | 84.88 | 84.88 | 84.88 | 84.88 |
| Accounts Payable | 2.5 | 2.3 | 1.5 | 2.4 | 1.0 | 3.1 | 3.5 | 3.9 | 4.4 | 4.9 |
| Accounts Payable, % | 46.3 | 46.27 | 30.43 | 45.59 | 12.33 | 36.18 | 36.18 | 36.18 | 36.18 | 36.18 |
| Capital Expenditure | -.3 | -.4 | .0 | .0 | .0 | -.2 | -.3 | -.3 | -.3 | -.4 |
| Capital Expenditure, % | -4.79 | -8.63 | 0 | 0.000027157988 | 0 | -2.68 | -2.68 | -2.68 | -2.68 | -2.68 |
| Tax Rate, % | 0.00718969 | 0.00718969 | 0.00718969 | 0.00718969 | 0.00718969 | 0.00718969 | 0.00718969 | 0.00718969 | 0.00718969 | 0.00718969 |
| EBITAT | -15.7 | -22.6 | -20.3 | -20.2 | -24.0 | -8.7 | -9.7 | -10.9 | -12.1 | -13.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -21.3 | -18.6 | -23.6 | -18.5 | -24.4 | -9.5 | -9.1 | -10.2 | -11.4 | -12.8 |
| WACC, % | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -45.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -13 | |||||||||
| Terminal Value | -402 | |||||||||
| Present Terminal Value | -311 | |||||||||
| Enterprise Value | -356 | |||||||||
| Net Debt | -36 | |||||||||
| Equity Value | -320 | |||||||||
| Diluted Shares Outstanding, MM | 25 | |||||||||
| Equity Value Per Share | -12.92 |
What You Will Get
- Comprehensive PROF Financials: Access to both historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Real-Time Calculations: Dynamic computation of intrinsic value and NPV.
- Scenario Analysis: Evaluate various scenarios to assess Profound Medical's future performance.
- User-Friendly Design: Crafted for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive PROF Data: Pre-loaded with Profound Medical Corp.'s historical financial metrics and future projections.
- Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital expenditures.
- Dynamic Valuation Framework: Instant updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation results.
- Intuitive Interface: Clean, organized, and tailored for both seasoned professionals and newcomers.
How It Works
- 1. Access the Template: Download and open the Excel file containing Profound Medical Corp.'s (PROF) preloaded data.
- 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures as needed.
- 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV in real-time.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation outcomes.
- 5. Utilize with Assurance: Present professional valuation insights to bolster your decision-making process.
Why Choose Profound Medical Corp. (PROF)?
- Innovative Solutions: Cutting-edge technology designed to enhance patient care and outcomes.
- Proven Results: Clinical evidence supports the effectiveness of our treatments.
- Patient-Centric Approach: Focused on improving the quality of life for patients through personalized care.
- Expert Team: Our professionals are leaders in the field, ensuring high standards and expertise.
- Commitment to Research: Ongoing investment in research and development to stay at the forefront of medical advancements.
Who Should Use Profound Medical Corp. (PROF)?
- Healthcare Investors: Make informed investment choices with cutting-edge medical technology insights.
- Medical Analysts: Streamline your analysis with comprehensive data on innovative treatment solutions.
- Consultants: Easily modify presentations or reports to showcase the latest advancements in medical procedures.
- Healthcare Enthusiasts: Enhance your knowledge of medical innovations through case studies and real-world applications.
- Educators and Students: Utilize it as a hands-on resource in healthcare and medical technology courses.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations specific to Profound Medical Corp. (PROF).
- Real-World Data: Profound Medical’s historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for deeper insights into Profound Medical's performance.
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage tailored to Profound Medical Corp. (PROF).
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results related to Profound Medical Corp. (PROF).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.